OQROGet OQRO Pro
Insider trade

Moderna (MRNA)CFO sold ~$2.67M

James M Mock, CFO at Moderna, sold ~$2.67M of Moderna shares.

~$2.67M
Approx. value · 20K sh @ $134.49
74K
Holds after · shares reported
Traded
Sep 10, 2026
Filed
Sep 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 15, 2026InsiderOfficer sold ~$3.61M of MRNA shares in the open market
  2. Jul 24, 20265% stakeBAILLIE GIFFORD & CO reported a passive stake (13G) of 4.6%
  3. Jul 31, 2026Company filing · Form 8-K · ResultsReported its results
  4. Aug 5, 2026Insider · 1 personInsiders: 4 sales (~$28.7M)
  5. Aug 6, 20265% stakeFMR LLC reported a passive stake (13G) of 13.1%
  6. Aug 12, 20265% stakeCapital World Investors reported a passive stake (13G) of 5.6%
  7. Aug 19, 2026Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  8. Aug 27, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 2 more items)
  9. Sep 1, 2026InsiderOfficer sold ~$486K of MRNA shares in the open market
  10. Sep 10, 2026 · this disclosureInsider · Their largest sale since 2023CFO sold ~$2.67M of MRNA shares in the open market

What came next

  1. Sep 10, 2026Insider · Their largest sale since 2023CFO sold ~$2.02M of MRNA shares in the open market
  2. Sep 14, 2026InsiderOfficer sold ~$5.81M of MRNA shares in the open market
  3. Sep 15, 2026InsiderOfficer sold ~$5.88M of MRNA shares in the open market
  4. Sep 24, 2026CongressDisclosed partial sale of MRNA — reported range $1,001 - $15,000
  5. Sep 30, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 30, 2026, Moderna, Inc. (“Moderna” or the “Company”) announced the appointment of Juan Andres as its Chief Operating Officer (“COO”) effective October 5, 2026.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Moderna

For Moderna, OQRO holds 13 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRNA page.

Other recent filings by James M Mock, Chief Financial Officer

The full history of James M Mock, Chief Financial Officer is on the profile page.

How this filing works

Other disclosures at Moderna

Everything OQRO holds on this company is on its MRNA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data